Barclays
SANA icon

Barclays’s Sana Biotechnology SANA Stock Holding History

Barclays’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Buy
49,357
+17,777
+56% +$57.3K ﹤0.01% 3797
2026
Q1 		$91K Sell
31,580
-478,309
-94% -$1.88M ﹤0.01% 4066
2025
Q4 		$2.08M Sell
509,889
-15,967
-3% -$71.5K ﹤0.01% 2910
2025
Q3 		$1.87M Buy
525,856
+31,441
+6% +$114K ﹤0.01% 2939
2025
Q2 		$1.35M Sell
494,415
-7,028
-1% -$14.5K ﹤0.01% 3130
2025
Q1 		$842K Buy
501,443
+182,960
+57% +$511K ﹤0.01% 3207
2024
Q4 		$519K Sell
318,483
-427
-0.1% -$1.27K ﹤0.01% 3798
2024
Q3 		$1.33M Buy
318,910
+178,179
+127% +$936K ﹤0.01% 3162
2024
Q2 		$768K Buy
140,731
+24,720
+21% +$197K ﹤0.01% 2759
2024
Q1 		$1.16M Sell
116,011
-234,603
-67% -$1.76M ﹤0.01% 2999
2023
Q4 		$1.43M Buy
350,614
+145,047
+71% +$534K ﹤0.01% 3177
2023
Q3 		$796K Buy
205,567
+6,096
+3% +$32.8K ﹤0.01% 2495
2023
Q2 		$1.19M Sell
199,471
-17,377
-8% -$100K ﹤0.01% 2196
2023
Q1 		$709K Sell
216,848
-86,262
-28% -$345K ﹤0.01% 2996
2022
Q4 		$1.2M Buy
303,110
+9,883
+3% +$48.3K ﹤0.01% 2661
2022
Q3 		$1.76M Buy
293,227
+264,030
+904% +$1.91M ﹤0.01% 1839
2022
Q2 		$188K Sell
29,197
-20,753
-42% -$132K ﹤0.01% 3465
2022
Q1 		$412K Buy
+49,950
New +$404K ﹤0.01% 3023

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Barclays's SANA Position: Q2 2026 in Review

Barclays increased its Sana Biotechnology (SANA) stake by 56% in Q2 2026, buying an estimated $57.3K and bringing the position to 49,357 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #3797.

Barclays first reported a position in SANA in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.08M in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Barclays held 49,357 shares of Sana Biotechnology worth $172K as of Q2 2026.
  • Barclays bought 17,777 Sana Biotechnology shares in Q2 2026, an estimated $57.3K.
  • Sana Biotechnology made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3797 holding.
  • Barclays first reported a position in Sana Biotechnology in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Sana Biotechnology position peaked at $2.08M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.